BackgroundBoth lncRNAs and glycolysis are considered to be key influencing factors in the progression of bladder cancer (BCa). Studies have shown that glycolysis-related lncRNAs are an important facto
This study aims to identify prognostic and therapy-response biomarkers in bladder cancer (BC) by developing a predictive gene signature based on myeloid cell differentiation-related genes (MCDGs) to e
Purpose To identify the predictive role of pretreatment skeletal muscle mass index (SMI) for long-term survival of bladder cancer patients. Methods Several databases were searched for studies investig
BackgroundBladder cancer is the most common malignancy of the urinary system. However, patient prognosis and treatment outcomes in bladder cancer are difficult to predict owing to high tumor heterogen
Multivariate analyses of WHO 2004 classification and other clinical parameters inferences to predict tumor recurrence and progression among patients with non-muscle-invasive bladder cancer.
